These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19292807)

  • 61. Letrozole as adjuvant endocrine therapy in postmenopausal women with breast cancer.
    Koeberle D; Thuerlimann B
    Expert Rev Anticancer Ther; 2006 Jan; 6(1):5-10. PubMed ID: 16375638
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Anastrozole: pharmacological and clinical profile in postmenopausal women with breast cancer.
    Köberle D; Thürlimann B
    Expert Rev Anticancer Ther; 2001 Aug; 1(2):169-76. PubMed ID: 12113022
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Intensification of a diffuse chronic pain syndrome by the introduction of an aromatase inhibitor].
    Nemitz N; Kurmann PT; Van Linthoudt D
    Praxis (Bern 1994); 2008 Feb; 97(3):137-41. PubMed ID: 18549014
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Case 24-2005: a woman with estrogen-receptor-positive breast cancer.
    Denes AE
    N Engl J Med; 2005 Nov; 353(21):2304-5; author reply 2304-5. PubMed ID: 16306534
    [No Abstract]   [Full Text] [Related]  

  • 65. Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer.
    Chapman JA; Meng D; Shepherd L; Parulekar W; Ingle JN; Muss HB; Palmer M; Yu C; Goss PE
    J Natl Cancer Inst; 2008 Feb; 100(4):252-60. PubMed ID: 18270335
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of neoadjuvant treatment with anastrozole on tumour histology in postmenopausal women with large operable breast cancer.
    Anderson TJ; Dixon JM; Stuart M; Sahmoud T; Miller WR
    Br J Cancer; 2002 Jul; 87(3):334-8. PubMed ID: 12177804
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Three patients with local recurrence of ER-positive breast cancer for whom anastrozole was clinically effective].
    Inari H; Hashimoto M; Uesugi K; Goto N; Hatori S; Tanabe H; Iwasaki H
    Gan To Kagaku Ryoho; 2013 Mar; 40(3):361-3. PubMed ID: 23507599
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [A case of inflammatory breast cancer responding to anastrozole].
    Sato T; Nakagawa T; Kuwayama T; Kubota K; Suzuki S; Sugihara K
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2477-9. PubMed ID: 20037461
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Anastrozole: brain draining or sparing?
    Berga SL
    Lancet Oncol; 2008 Oct; 9(10):913-4. PubMed ID: 19071243
    [No Abstract]   [Full Text] [Related]  

  • 70. Evaluating Markers for Guiding Treatment.
    Baker SG; Bonetti M
    J Natl Cancer Inst; 2016 Sep; 108(9):. PubMed ID: 27193772
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Quantification of hormone receptors to guide adjuvant therapy choice in early breast cancer: better methods required for improved utility.
    Bartlett JM; Rea D; Rimm DL
    J Clin Oncol; 2011 Sep; 29(27):3715-6. PubMed ID: 21810678
    [No Abstract]   [Full Text] [Related]  

  • 72. Phase II trial of decapeptyl (D-TRP-6), a potent luteinizing hormone-releasing hormone analogue in untreated advanced breast cancer.
    Garcia-Giralt E; Beuzeboc P; Dieras V; Dorval T; Jouve M; Livartowski A; Palangie T; Scholl S; Pouillart P
    Am J Clin Oncol; 1996 Oct; 19(5):455-8. PubMed ID: 8823473
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Association of Survival With Chemoendocrine Therapy in Women With Small, Hormone Receptor-Positive, ERBB2-Positive, Node-Negative Breast Cancer.
    Ma SJ; Oladeru OT; Singh AK
    JAMA Netw Open; 2020 Apr; 3(4):e202507. PubMed ID: 32271387
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The role of microRNAs in breast cancer migration, invasion and metastasis.
    Tang J; Ahmad A; Sarkar FH
    Int J Mol Sci; 2012 Oct; 13(10):13414-37. PubMed ID: 23202960
    [TBL] [Abstract][Full Text] [Related]  

  • 75. PPARγ antagonist GW9662 induces functional estrogen receptor in mouse mammary organ culture: potential translational significance.
    Mehta RG; Peng X; Roy S; Hawthorne M; Kalra A; Alimirah F; Mehta RR; Kopelovich L
    Mol Cell Biochem; 2013 Jan; 372(1-2):249-56. PubMed ID: 23001870
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Molecular therapy of breast cancer: progress and future directions.
    Lin SX; Chen J; Mazumdar M; Poirier D; Wang C; Azzi A; Zhou M
    Nat Rev Endocrinol; 2010 Sep; 6(9):485-93. PubMed ID: 20644568
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Enhancing the adjuvant treatment of hormone receptor positive breast cancer.
    Barry M; Kell MR
    Breast J; 2009; 15(2):194-8. PubMed ID: 19292807
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial.
    Jakesz R; Jonat W; Gnant M; Mittlboeck M; Greil R; Tausch C; Hilfrich J; Kwasny W; Menzel C; Samonigg H; Seifert M; Gademann G; Kaufmann M; Wolfgang J;
    Lancet; 2005 Aug 6-12; 366(9484):455-62. PubMed ID: 16084253
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
    Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
    J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor-Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial.
    Smith I; Yardley D; Burris H; De Boer R; Amadori D; McIntyre K; Ejlertsen B; Gnant M; Jonat W; Pritchard KI; Dowsett M; Hart L; Poggio S; Comarella L; Salomon H; Wamil B; O'Shaughnessy J
    J Clin Oncol; 2017 Apr; 35(10):1041-1048. PubMed ID: 28113032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.